NLRP3 and major depressive disorder: It has been found that after depression treatment, the target of cure was focused on purine metabolism, and by targeting quantitative analysis of purine metabolites in the cortex, it was confirmed that excessive synthesis of the purine metabolite xanthine may mediate activation of the NLRP3 inflammatory vesicle pathway, leading to depression (Chen et al.